Tranilast Inhibits TGF-β1–induced Epithelial-mesenchymal Transition and Invasion/Metastasis <i>via</i> the Suppression of Smad4 in Human Lung Cancer Cell Lines

Koji Takahashi(Kyoto University), Hiroshi Date(Kyoto University)

Anticancer Research

June 1, 2020

10.21873/anticanres.14311

Cited by 28

Related Papers

Association between epithelial‐mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma

|Cancer Medicine|2015|51

M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma

|Cancer Science|2023|30

The synergistic role of <scp>ATP</scp>‐dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancer

|Cancer Medicine|2018|27

A novel cell-based assay for the high-throughput screening of epithelial–mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial–mesenchymal transition

|Lung Cancer|2022|2

The novel compound PICCS improves cell viability during cold storage and reduces pulmonary ischemia-reperfusion injury in a rat model

|Scientific Reports|2025|1